Real-World Effectiveness of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Population-Based Study in South Korea

Author

Kim S and Suh HS

Journal

The 2022 International Society for Pharmacoeconomics and Outcomes Research

Remarks

Washington, DC, USA. May 2022.